Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. is a pioneering biotechnology research company dedicated to developing curative genome editing treatments. Located at 40 Erie Street, Cambridge, Massachusetts 02139, US, Intellia Therapeutics, Inc. is focused on transforming the lives of individuals affected by severe and life-threatening diseases through innovative gene editing solutions.

Leveraging the revolutionary CRISPR/Cas9 system, Intellia Therapeutics, Inc. is at the forefront of medical advancements, aiming to permanently edit disease-associated genes within the human body. This groundbreaking approach offers the potential for developing curative therapeutic options for patients suffering from chronic diseases, directly addressing the underlying causes and bringing hope to those in need.

With a commitment to innovation and a vision for the future of medicine, Intellia Therapeutics, Inc. continues to push the boundaries of biotechnology. We invite the manager of Intellia Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform, enhancing your company's visibility and commercial development.